Himax and Liqxtal to Launch New Pro-Eye Vision Care Monitor Featuring WiseEye™ AI Tracking at the 2025 Taiwan Healthcare+ Expo

Rhea-AI Summary

Himax (Nasdaq: HIMX) and Liqxtal announced the Liqxtal Pro-Eye vision-care monitor, featuring Himax’s WiseEye™ AI facial-recognition and eye-tracking, to be presented at the 2025 Taiwan Healthcare+ Expo (Dec 4–7, Taipei Nangang Hall 1).

Company-reported research findings state the Pro-Eye’s electrically tunable liquid-crystal optics project a virtual viewing distance of ~16 feet, aiming to reduce ciliary-muscle strain from near-screen use, alleviate eye fatigue and blurred vision in seniors and heavy device users, and lower pseudo-myopia risk in school-age children. The monitor also offers flicker-free design, low-blue-light calibration, privacy shielding, and personalized AI eye-use reports.

News Market Reaction – HIMX

-0.53%

-0.53% Session close to close

In the Dec 1 session, HIMX declined 0.53%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Himax’s extension of WiseEye ultralow power AI into Liqxtal’s Pro-Eye v...

Analysis

This announcement highlights Himax’s extension of WiseEye ultralow power AI into Liqxtal’s Pro-Eye vision-care monitor, projecting images at about 16 feet to reduce near-screen strain. It fits a pattern of AI-centric initiatives across PCs, wearables, and biometrics. Investors may track adoption of this eye-care display, the breadth of WiseEye design-wins, and upcoming financial updates to gauge how these AI efforts translate into revenue and margins over time.

Key Figures

Virtual viewing distance: approximately 16 feet Standard screen distance: 20 to 24 inches Healthcare+ Expo dates: December 4 to 7, 2025 +1 more

4 metrics

Virtual viewing distance approximately 16 feet Pro-Eye monitor optical design

Standard screen distance 20 to 24 inches Typical near-screen viewing comparison

Healthcare+ Expo dates December 4 to 7, 2025 2025 Taiwan Healthcare+ Expo schedule

Exhibition hall Hall 1 Taipei Nangang Exhibition Center location

Historical Context

5 past events · Latest: Dec 01 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Dec 01	AI product launch	Positive	-0.5%	Launch of Pro-Eye AI vision-care monitor targeting reduced visual strain.
Nov 06	Earnings results	Positive	-12.9%	Q3 2025 beat on guidance with cautious outlook and flat Q4 guidance.
Oct 14	AI security demo	Positive	+2.1%	WiseEye palm vein authentication demo with on-device AI and GDPR focus.
Oct 07	Earnings call notice	Neutral	-2.0%	Scheduling details for Q3 2025 financial results conference call.
Sep 24	AI PC design-win	Positive	+1.1%	WiseEye AI sensing adopted in Acer Swift Edge 14 AI notebook.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent AI and partnership news generally saw modest positive or mixed price reactions, while the latest AI eye-care monitor and Q3 earnings each faced negative follow-through despite constructive narratives.

Recent Company History

Over the last six months, Himax emphasized ultralow-power AI and WiseEye across multiple applications. AI sensing appeared in wearables, PCs, biometrics, and now eye-care monitors, including today’s Pro-Eye launch for the 2025 Taiwan Healthcare+ Expo. Q3 2025 results showed $199.2M revenue and a small profit beat but drew a -12.94% reaction. Prior AI showcases with Acer and Sectech Sweden saw modest gains, while some AI collaborations and today’s Pro-Eye news produced slight declines.

Key Terms

electrically controlled liquid crystal, ciliary-muscle, pseudo-myopia, flicker-free, +4 more

8 terms

electrically controlled liquid crystal technical

"Combining Liqxtal’s Patented Electrically Controlled Liquid Crystal Technology"

A material whose light-blocking or light-bending behavior changes when an electric voltage is applied, like a window that goes from foggy to clear with a switch. Investors care because this switchable property is used in screens, smart glass and optical devices, affecting product performance, manufacturing complexity and market demand—so advances or supply issues can influence sales and costs.

ciliary-muscle medical

"helps reduce ciliary-muscle strain caused by prolonged near-screen use"

A ciliary muscle is a small ring of muscle inside the eye that changes the shape of the lens to focus on near or far objects and helps regulate fluid flow around the eye, like a built‑in focus knob and drainage pump. It matters to investors because drugs, medical devices, or surgeries that affect this muscle can treat common conditions such as glaucoma or age-related focusing problems, shaping market size, clinical trial outcomes, and regulatory approvals.

pseudo-myopia medical

"effectively lower the risk of pseudo-myopia in school-age children"

A temporary form of nearsightedness caused when the eye’s focusing muscle locks in a near-focus state, making distant objects appear blurry; it often follows prolonged close work, certain medications, or eye strain and usually clears with rest or specific eye drops. Investors track pseudo-myopia because it can change demand for eye exams, corrective lenses, and treatments, affect clinical trial measurements for ophthalmic products, and influence regulatory or market assessments for vision-related technologies.

flicker-free technical

"Together with the monitor’s flicker-free design, low blue-light calibration"

Flicker-free describes lighting or display technology designed to emit a steady, continuous image or light without perceptible rapid fluctuations in brightness. For investors, it signals better product quality and user comfort—reducing eye strain, headaches, and potential health or safety complaints—and can be a competitive differentiator that affects sales, returns, warranty claims, and regulatory scrutiny, much like a smoothly running engine versus one that jerks intermittently.

low blue-light technical

"flicker-free design, low blue-light calibration, and a suite of eye-care"

Low blue-light describes screens, bulbs or filters designed to emit less short-wavelength (blue) light that can contribute to eye strain and disrupt sleep patterns; think of it as sunglasses built into a device or lamp to soften a harsh tint. For investors, it matters because it’s a marketable product feature tied to consumer well‑being, regulatory claims and certification standards that can influence sales, pricing power and liability exposure.

AI sensing technical

"Featuring Himax’s WiseEye™ ultralow power AI sensing technology, Pro-Eye"

AI sensing is the use of artificial intelligence to interpret data from physical sensors—like cameras, microphones, temperature or motion detectors—to detect patterns, anomalies, or predictions that humans might miss. For investors, it signals potential for products or services that cut costs, improve safety or performance, and create recurring revenue streams; think of it as a smart watchdog that turns raw signals into actionable decisions that can boost efficiency and reduce unexpected losses.

eye tracking technical

"WiseEye™ AI facial recognition and eye-tracking technology, will be presented"

Eye tracking is technology that records where people look and how their eyes move, producing data about attention and visual behavior. For investors, it matters because those insights reveal which parts of a product, website, ad or medical test capture attention and drive engagement — like a heat map showing what customers notice — helping predict user adoption, optimize marketing spend, assess product design, or signal clinical utility.

privacy-protection angled shielding display technical

"Its built-in privacy-protection angled shielding display effectively prevents"

A privacy-protection angled shielding display is a screen engineered to limit visibility from side angles so only the person directly in front can clearly see the content, like a louvered window that blocks side views. For investors it matters because it can be a product differentiator that commands higher prices, affects manufacturing complexity and component costs, and responds to consumer and regulatory demand for on-device privacy, all of which can influence sales, margins, and competitive positioning.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Combining Liqxtal’s Patented Electrically Controlled Liquid Crystal Technology and Himax’s WiseEye AI to Reduce Visual Strain for a More Comfortable Eye-Care Experience for Senior Users and Heavy Digital-Device Users

TAINAN, Taiwan, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, and Liqxtal Technology Inc. (“Liqxtal”), a subsidiary of Himax dedicated to developing various image and optical solutions with exceptional adaptive optics design and manufacturing expertise, today announced that the latest Liqxtal® Pro-Eye vision-care monitor, equipped with Himax’s WiseEye™ AI facial recognition and eye-tracking technology, will be presented at the upcoming 2025 Taiwan Healthcare+ Expo. At the event, Liqxtal will also unveil the research findings on the Pro-Eye monitor for the first time. The results show that the Pro-Eye monitor’s long-distance viewing design helps reduce ciliary-muscle strain caused by prolonged near-screen use, alleviating common issues such as eye fatigue and blurred vision among senior users and intensive digital-device users. The findings also indicate that it can effectively lower the risk of pseudo-myopia in school-age children, marking a significant milestone in the intelligent vision-care display technologies.  

The Liqxtal^® Pro-Eye vision-care monitor features three major technological innovations:

• Proprietary optical architecture: Leveraging Liqxtal’s patented electrically tunable liquid crystal technology, the Pro-Eye monitor projects images to a virtual viewing distance of approximately 16 feet away, compared with standard screens typically viewed at 20 to 24 inches, while maintaining exceptional clarity, sharpness without distortion. This design reduces eye strain and the burden of near-far adjustment caused by presbyopia, providing users with a more relaxed viewing distance when looking at the screen. Together with the monitor’s flicker-free design, low blue-light calibration, and a suite of eye-care enhancements, Pro-Eye ensures all-around visual protection.
• AI-powered eye monitoring and data integration: Featuring Himax’s WiseEye™ ultralow power AI sensing technology, Pro-Eye performs real-time AI face and eye tracking to monitor visual behavior and analyze gaze patterns. It automatically generates personalized eye-use reports, determines whether the user’s viewing distance remains within the optimal range, and provides alerts to help prevent excessive eye strain or poor posture. These data-driven insights help users develop healthier viewing habits, including taking regular breaks and maintaining proper viewing distance.
• Cross-domain vision protection: Designed for a wide range of environments, including medical clinics, entertainment at home, and remote-work setups, where Pro-Eye offers an all-day, multi-scenario eye-care solution. Its built-in privacy-protection angled shielding display effectively prevents side-view peeking, enhancing information security in business settings.
  
  

“Pro-Eye not only delivers meaningful visual improvement for users who spend extended hours in front of screens, but also represents a new era of eye-protection technology through the deep integration of optics and AI. With precise AI-driven visual-behavior analysis and real-time gaze monitoring, our goal is to transform the display from a passive viewing device into an intelligent interface that proactively safeguards users’ visual health. Looking ahead, we will continue collaborating with academic and medical institutions to strengthen both theoretical and clinical research, driving ongoing refinement and real-world adoption of vision-care technologies,” said by Dr. Hung Shan Chen, President of Liqxtal.

The Taiwan Healthcare+ Expo brings together the latest achievements in smart healthcare, biopharmaceuticals, precision medicine, medical devices, and electronic technologies, serving as a key international platform for cross-disciplinary collaboration. The 2025 exhibition will take place from December 4 to 7 at Taipei Nangang Exhibition Center, Hall 1.

During the event, Himax will also showcase a wide range of innovative applications powered by WiseEye ultralow power AI sensing technology. We warmly invite media representatives and industry professionals to visit us at Booth I1109a to experience the latest advancements in vision-care monitor and AI-driven innovations firsthand.

About Liqxtal Technology Inc.

Liqxtal Technology Inc. is a Taiwan based company that has been focused on exploring opportunities with liquid crystal (“LC”) beyond just displays since the company’s inception. With a distinguished track record in liquid crystal optics, Liqxtal has developed liquid crystal based optical components such as LC lens for ophthalmic application, LC diffuser for 3D sensing and LC retarder for light sensing. Additionally, Liqxtal designed and released LQ001, a high voltage & tunable frequency LC driver with a 1mm x 2mm footprint, which is particularly ideal for portable products. As a subsidiary of Himax Technologies, Liqxtal also integrates novel display solutions such as tunable backlight with local dimming capability powered by FPGA for niche applications. Lastly, Liqxtal is dedicated to novel vision eyewear technology and strives to innovate and advance useful optical solutions to the world.

https://www.himax.com.tw/zh/products/liqxtal-technology/

About Himax Technologies, Inc.

Himax Technologies, Inc. (NASDAQ: HIMX) is a leading global fabless semiconductor solution provider dedicated to display imaging processing technologies. The Company’s display driver ICs and timing controllers have been adopted at scale across multiple industries worldwide including TVs, PC monitors, laptops, mobile phones, tablets, automotive, ePaper devices, industrial displays, among others. As the global market share leader in automotive display technology, the Company offers innovative and comprehensive automotive IC solutions, including traditional driver ICs, advanced in-cell Touch and Display Driver Integration (TDDI), local dimming timing controllers (Local Dimming Tcon), Large Touch and Display Driver Integration (LTDI) and OLED display technologies. Himax is also a pioneer in tinyML visual-AI and optical technology related fields. The Company’s industry-leading WiseEye™ Ultralow Power AI Sensing technology which incorporates Himax proprietary ultralow power AI processor, always-on CMOS image sensor, and CNN-based AI algorithm has been widely deployed in consumer electronics and AIoT related applications. Himax optics technologies, such as diffractive wafer level optics, LCoS microdisplays and 3D sensing solutions, are critical for facilitating emerging AR/VR/metaverse technologies. Additionally, Himax designs and provides touch controllers, OLED ICs, LED ICs, EPD ICs, power management ICs, and CMOS image sensors for diverse display application coverage. Founded in 2001 and headquartered in Tainan, Taiwan, Himax currently employs around 2,200 people from three Taiwan-based offices in Tainan, Hsinchu and Taipei and country offices in China, Korea, Japan, Germany, and the US. Himax has 2,586 patents granted and 371 patents pending approval worldwide as of September 30, 2025.

http://www.himax.com.tw

Forward Looking Statements

Factors that could cause actual events or results to differ materially from those described in this conference call include, but are not limited to, the effect of the Covid-19 pandemic on the Company’s business; general business and economic conditions and the state of the semiconductor industry; market acceptance and competitiveness of the driver and non-driver products developed by the Company; demand for end-use applications products; reliance on a small group of principal customers; the uncertainty of continued success in technological innovations; our ability to develop and protect our intellectual property; pricing pressures including declines in average selling prices; changes in customer order patterns; changes in estimated full-year effective tax rate; shortage in supply of key components; changes in environmental laws and regulations; changes in export license regulated by Export Administration Regulations (EAR); exchange rate fluctuations; regulatory approvals for further investments in our subsidiaries; our ability to collect accounts receivable and manage inventory and other risks described from time to time in the Company's SEC filings, including those risks identified in the section entitled "Risk Factors" in its Form 20-F for the year ended December 31, 2024 filed with the SEC, as may be amended.

Liqxtal Contact:

Henry Hung, Deputy Director of Market & Sales Division
Liqxtal Technology Inc.
Tel: +886-6-505-0880
Email: info@liqxtal.com

Himax Contacts:

Karen Tiao, Head of IR/PR
Himax Technologies, Inc.
Tel: +886-2-2370-3999
Fax: +886-2-2314-0877
Email: hx_ir@himax.com.tw
www.himax.com.tw

Mark Schwalenberg, Director
Investor Relations - US Representative
MZ North America
Tel: +1-312-261-6430
Email: HIMX@mzgroup.us
www.mzgroup.us

FAQ

When and where will Himax present the Pro-Eye monitor (HIMX) at the Taiwan Healthcare+ Expo 2025?

Himax and Liqxtal will present the Pro-Eye monitor at the Taiwan Healthcare+ Expo, Dec 4–7, 2025, at Taipei Nangang Exhibition Center Hall 1 and Booth I1109a.

What is WiseEye AI on the Pro-Eye monitor (HIMX) and what does it do?

WiseEye™ is Himax’s ultralow-power AI sensing that performs real-time face and eye tracking to generate personalized eye-use reports and alerts for viewing distance and posture.

How does the Liqxtal Pro-Eye monitor (HIMX) reduce eye strain compared with standard screens?

The Pro-Eye uses electrically tunable liquid-crystal optics to project a virtual viewing distance of about 16 feet versus typical 20–24 inches, combined with flicker-free and low-blue-light calibration to reduce near-screen strain.

Does the Pro-Eye monitor (HIMX) claim clinical benefits for children or seniors?

The announced research findings indicate the monitor may lower pseudo-myopia risk in school-age children and alleviate ciliary-muscle strain and eye fatigue in seniors and heavy device users.

What environments is the Pro-Eye monitor (HIMX) designed for?

Pro-Eye targets multiple scenarios including medical clinics, home entertainment, and remote-work setups, offering all-day vision protection and a privacy-protection angled shielding display.

How can investors or attendees experience Himax’s Pro-Eye and WiseEye demos at the expo?

Attendees and media can visit Himax at Booth I1109a during Dec 4–7, 2025, to view live demonstrations of Pro-Eye and WiseEye AI sensing applications.